A FZD7-specific Antibody-Drug Conjugate Induces Ovarian Tumor Regression in Preclinical Models.
Do M, Wu CCN, Sonavane PR, Juarez EF, Adams SR, Ross J, Rodriguez Y Baena A, Patel C, Mesirov JP, Carson DA, Advani SJ, Willert K.
Do M, et al. Among authors: rodriguez y baena a.
Mol Cancer Ther. 2022 Jan;21(1):113-124. doi: 10.1158/1535-7163.MCT-21-0548. Epub 2021 Oct 19.
Mol Cancer Ther. 2022.
PMID: 34667113
Free PMC article.